ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
CAR-T
1,448.62
+18.42
1.29%
涨家数:
2
跌家数:
- -
平家数:
- -
市盈率:
- -
高:
1,459.15
开:
1,433.19
低:
1,433.19
收:
1,430.23
数据加载中...
总览
新闻
财报前瞻:诺华Q2能否延续双位数增长?核心药物+创新疗法成关键引擎
财报Agent
·
昨天
诺华制药6月30日成交额为1.55亿美元
市场透视
·
昨天
吉利德科学6月30日成交额为7.31亿美元
市场透视
·
昨天
吉利德科学公司在最高法院维持奥巴马医改条款后股价继续上涨
英为财情
·
06-30
据吉利德科学消息6月30日lenacapavir(来那帕韦)作为HIV暴露前预防(PrEP)药物在海南博鳌乐城国际医疗旅
智通财经
·
06-30
美国最高法院就预防性医保做出裁决后,吉利德股价上涨
路透中文
·
06-27
吉利德科学盘中异动 早盘股价大涨3.10%报110.96美元
市场透视
·
06-27
RSV感染率太低,吉利德砍掉2项试验?
生物制品圈
·
06-27
诺华制药6月26日成交额为1.97亿美元
市场透视
·
06-27
吉利德科学6月25日成交额为6.40亿美元
市场透视
·
06-26
BUZZ-Kymera Therapeutics 发行 2.5 亿美元股票后下跌
路透中文
·
06-26
吉利德与 Kymera Therapeutics 签订价值 7.5 亿美元的抗癌药物协议
路透中文
·
06-25
诺华制药6月24日成交额为1.23亿美元
市场透视
·
06-25
吉利德科学6月24日成交额为8.48亿美元
市场透视
·
06-25
诺华制药6月23日成交额为1.35亿美元
市场透视
·
06-24
吉利德科学6月23日成交额为8.69亿美元
市场透视
·
06-24
诺华制药6月20日成交额为2.87亿美元
市场透视
·
06-21
吉利德科学6月20日成交额为25.27亿美元
市场透视
·
06-21
美股异动丨吉利德科学盘前涨超2% 艾滋病预防明星药获美国FDA批准
格隆汇
·
06-20
【高盛:予吉利德(GILD.US)“中性”评级 长效HIV疗法迎来重大机遇】智通财经APP获悉,高盛发布研报,予吉利德科
智通财经
·
06-20
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4578/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T","latestPrice":1448.6537,"timestamp":1751395494711,"preClose":1430.2296,"halted":0,"volume":4866984,"delay":0,"changeRate":0.012882,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":18.424072,"latestTime":"07-01 14:44:56 EDT","open":1433.1947,"high":1459.1499,"low":1433.1947,"amount":555135744.031174,"amplitude":0.018148,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1751400000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.511103,"peRate":19.899613,"turnoverRate":0.001566,"increases":2,"decrements":0,"flats":0,"marketCap":379834499072,"floatMarketCap":368228270080},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1459.1499,"amplitude":0.018148,"preClose":1430.2296,"low":1433.1947,"pbRate":"6.511103","latestPrice":1448.6163,"volume":4867298,"delay":0,"open":1433.1947,"prevYearClose":1164.883,"prevWeekClose":1422.1819,"prevMonthClose":1430.2296,"prevQuarterClose":1430.2296,"fiveDayClose":1396.6683,"twentyDayClose":1388.7247,"sixtyDayClose":1371.8842,"secType":"PLATE","market":"US","turnoverRate":0.001566,"peRate":19.899613,"marketCap":379834499072,"floatMarketCap":368228270080,"timestamp":1751395497000,"nameCN":"CAR-T"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":2,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1196895616","title":"财报前瞻:诺华Q2能否延续双位数增长?核心药物+创新疗法成关键引擎","url":"https://stock-news.laohu8.com/highlight/detail?id=1196895616","media":"财报Agent","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196895616?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 13:09","pubTimestamp":1751346579,"startTime":"0","endTime":"0","summary":"$诺华$公司将于7月17日美股盘前公布25财年第二季度财报。本季度展望重点业务动能公司延续深耕针对重大疾病的核心药物组合,通过多国市场的准入与推广,巩固品牌口碑和影响力。分析师观点多家机构研究报告纷纷给予诺华公司较为积极的评价,认定其在重大适应症与新疗法领域的投入正逐渐体现出成效。","market":"us","thumbnail":"https://static.tigerbbs.com/8172004573fe340713c0fd5578ba3471","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8172004573fe340713c0fd5578ba3471"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻:诺华Q2能否延续双位数增长?核心药物+创新疗法成关键引擎","news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU0208291251.USD","LU0211331839.USD","BK4585","LU0320765489.SGD","LU0070302665.USD","BK4588","IE00B4R5TH58.HKD","NVS","IE00B2B36J28.USD","IE0009355771.USD","BK4578","BK4532","IE00BJT1NW94.SGD","BK4007","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2548026066","title":"诺华制药6月30日成交额为1.55亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548026066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548026066?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 12:06","pubTimestamp":1751342809,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日,诺华制药成交额为1.55亿美元,成交额较昨日减少16.36%,当日成交量为128.08万股。诺华制药于2025年6月30日涨0.83%,报121.01美元,该股过去5个交易日涨2.97%,年初至今涨29.68%,过去60日涨9.24%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-30|1.55亿|-16.36%|128.08万|#|2025-06-27|1.85亿|-5.88%|154.08万|#|2025-06-26|1.97亿|78.32%|163.85万|#|2025-06-25|1.10亿|-10.66%|93.47万|#|2025-06-24|1.23亿|-8.26%|104.07万|诺华开发和生产创新药物。该公司的产品销往全球,其中美国占总收入的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701120658a4c80920&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701120658a4c80920&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002141913.USD","IE00BJT1NW94.SGD","BK4578","LU0070302665.USD","LU0320765489.SGD","BK4588","IE00BFTCPJ56.SGD","BK4532","LU0211331839.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","IE0009355771.USD","NVS","IE00B2B36J28.USD","BK4585","IE00B4R5TH58.HKD","BK4007"],"gpt_icon":0},{"id":"2548028892","title":"吉利德科学6月30日成交额为7.31亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548028892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548028892?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 10:09","pubTimestamp":1751335744,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日,吉利德科学成交额为7.31亿美元,成交额较昨日减少66.06%,当日成交量为660.23万股。吉利德科学于2025年6月30日涨0.18%,报110.87美元,该股过去5个交易日涨4.41%,年初至今涨21.74%,过去60日跌0.2%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权,该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701100905a727485e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701100905a727485e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z3B42.SGD","SG9999015986.USD","BK4578","IE00B19Z3581.USD","LU1585245621.USD","LU0109394709.USD","LU0058720904.USD","LU1066051498.USD","LU1571399168.USD","GILD","BK4532","IE00BSNM7G36.USD","BK4568","LU1674673691.USD","LU2324357040.USD","IE0002270589.USD","BK4588","LU2089984988.USD","SG9999015952.SGD","BK4583","LU0320765992.SGD","LU1066053197.SGD","BK4550","LU1778281490.HKD","LU1839511570.USD","IE00BKVL7J92.USD","LU2468319806.SGD","IE00BZ1G4Q59.USD","LU0889565916.HKD","LU1674673428.USD","BK4566","IE00B3T34201.USD","LU1430594728.SGD","IE00B7SZLL34.SGD","LU0823416689.USD","LU0234570918.USD","SG9999015945.SGD","BK4139","SG9999015978.USD","LU2087621335.USD","LU0289739699.SGD","BK4585"],"gpt_icon":0},{"id":"2547990400","title":"吉利德科学公司在最高法院维持奥巴马医改条款后股价继续上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2547990400","media":"英为财情","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547990400?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 19:27","pubTimestamp":1751282820,"startTime":"0","endTime":"0","summary":"Investing.com - 美国最高法院维持了《平价医疗法案》的一项条款,该条款要求保险公司为患者提供预防性服务,如艾滋病预防和癌症筛查,且不向患者收取额外费用。这一消息使吉利德科学公司股价在周五上涨了2.8%,并在周一盘前交易中略微扩大了涨幅。分析师们继续预计,Yeztugo将为市场扩张做出重大贡献,并为吉利德科学公司的业务增添长期实力。吉利德科学公司此前曾表示,预计在产品推出后六个月内实现约75%的覆盖率,并在第一年结束时达到约90%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cn.investing.com/news/stock-market-news/article-2866002","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"吉利德科学公司在最高法院维持奥巴马医改条款后股价继续上涨","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"investing_news","symbols":["LU2087621335.USD","BK4566","BK4588","SG9999015945.SGD","IE00B7SZLL34.SGD","LU0289739699.SGD","LU1674673428.USD","LU0109394709.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","BK4139","IE00BSNM7G36.USD","LU2089984988.USD","IE00BKVL7J92.USD","LU2324357040.USD","LU1839511570.USD","LU1066051498.USD","LU1585245621.USD","LU2468319806.SGD","IE00B3T34201.USD","LU1778281490.HKD","BK4583","LU1066053197.SGD","BK4578","IE0002270589.USD","LU0234570918.USD","LU1430594728.SGD","SG9999015986.USD","BK4568","BK4550","LU0058720904.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","LU1674673691.USD","SG9999015952.SGD","SG9999015978.USD","GILD","LU0823416689.USD","IE00B19Z3581.USD","LU1571399168.USD","BK4585","BK4532"],"gpt_icon":0},{"id":"2547580680","title":"据吉利德科学消息6月30日lenacapavir(来那帕韦)作为HIV暴露前预防(PrEP)药物在海南博鳌乐城国际医疗旅","url":"https://stock-news.laohu8.com/highlight/detail?id=2547580680","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547580680?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 12:03","pubTimestamp":1751256194,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2468319806.SGD","IE0002270589.USD","GILD","BK4568","BK1574","159891","IE00BKVL7J92.USD","SG9999015978.USD","BK4532","LU0320765992.SGD","BK4550","LU1585245621.USD","IE00B7SZLL34.SGD","LU1674673691.USD","IE00B19Z3581.USD","LU2087621335.USD","159992","BK4585","LU1839511570.USD","LU0289739699.SGD","LU0058720904.USD","LU0889565916.HKD","BK4578","SG9999015945.SGD","LU1571399168.USD","SG9999015952.SGD","BK4139","LU1430594728.SGD","IE00BZ1G4Q59.USD","06978","LU1066051498.USD","LU1674673428.USD","LU1778281490.HKD","BK4588","SG9999015986.USD","LU0823416689.USD","LU0234570918.USD","LU0109394709.USD","LU1066053197.SGD","IE00BSNM7G36.USD","BK4566","IE00B3T34201.USD","BK4583","LU2089984988.USD","BK1161","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2546742229","title":"美国最高法院就预防性医保做出裁决后,吉利德股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2546742229","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546742229?lang=zh_cn&edition=fundamental","pubTime":"2025-06-27 22:52","pubTimestamp":1751035952,"startTime":"0","endTime":"0","summary":"美国最高法院就预防性医保做出裁决后,吉利德股价上涨路透6月27日 - 吉利德GILD.O的股价上涨了近3%,因为美国最高法院周五保留了奥巴马医改法的一个关键要素,该要素有助于保证医疗保险公司免费为患者提供预防性医疗服务。第五巡回法院于 2024 年裁定,该工作组的结构违反了宪法。分析师在判决前曾警告说,任何不利的决定都可能减少低收入和年轻患者的接受率,从而拖累吉利德的艾滋病预防收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nL4S3SU0Y2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","LU1670756490.USD","SG9999011175.SGD","SG9999015986.USD","BK4585","LU1883839398.USD","BK5011","IE0002270589.USD","LU0289739699.SGD","GILD","LU0203345920.USD","LU0575583348.USD","IE0034235071.USD","BK4568","BK4581","LU0306807586.USD","BK4578","BK4583","BK4532","BK4139","LU1057294990.SGD","IE00B3T34201.USD","LU1302929846.USD","LU0306806265.USD","IE00BSNM7G36.USD","LU1098665638.USD","LU1202635105.USD","BK4533","LU1066051498.USD","LU1228905037.USD","LU1400636491.USD","IE00B19Z3B42.SGD","LU0211331839.USD","LU2089984988.USD","IE00BBT3K403.USD","SG9999015978.USD","PFE","IE00BLSP4239.USD","LU1400636574.HKD","LU0203347892.USD","LU2468319806.SGD","LU0109394709.USD","LU0971552830.HKD","LU1894683348.USD","SG9999015952.SGD","GSK.UK","SG9999001176.USD","LU0868494617.USD","BK4550","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"2546421197","title":"吉利德科学盘中异动 早盘股价大涨3.10%报110.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546421197","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546421197?lang=zh_cn&edition=fundamental","pubTime":"2025-06-27 22:32","pubTimestamp":1751034760,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日22时32分,吉利德科学股票出现波动,股价快速拉升3.10%。截至发稿,该股报110.96美元/股,成交量242.035万股,换手率0.19%,振幅3.70%。最近的财报数据显示,该股实现营业收入66.46亿美元,净利润13.15亿美元,每股收益1.06美元,毛利51.06亿美元,市盈率23.15倍。吉利德科学股票所在的制药行业中,整体涨幅为0.12%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权,该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627223240952e3a97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627223240952e3a97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B3T34201.USD","SG9999015952.SGD","IE0002270589.USD","LU0234570918.USD","LU1839511570.USD","BK4578","SG9999015945.SGD","LU2089984988.USD","BK4588","LU1066051498.USD","BK4139","BK4568","IE00BZ1G4Q59.USD","LU1585245621.USD","LU1430594728.SGD","LU0058720904.USD","LU0889565916.HKD","BK4583","IE00BSNM7G36.USD","LU1674673691.USD","LU2468319806.SGD","IE00B19Z3B42.SGD","BK4566","LU0289739699.SGD","GILD","IE00BKVL7J92.USD","LU1778281490.HKD","LU2087621335.USD","SG9999015986.USD","LU1674673428.USD","SG9999015978.USD","LU1066053197.SGD","LU0320765992.SGD","IE00B7SZLL34.SGD","LU0823416689.USD","LU0109394709.USD","LU1571399168.USD","IE00B19Z3581.USD","BK4585","BK4532","BK4550"],"gpt_icon":0},{"id":"2546971247","title":"RSV感染率太低,吉利德砍掉2项试验?","url":"https://stock-news.laohu8.com/highlight/detail?id=2546971247","media":"生物制品圈","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546971247?lang=zh_cn&edition=fundamental","pubTime":"2025-06-27 17:58","pubTimestamp":1751018281,"startTime":"0","endTime":"0","summary":"公司寄予厚望的抗病毒药物 obeldesivir,两项正在进行的中期试验被迫终止。原因堪称魔幻 —— 上一季节呼吸道合胞病毒感染率低到离谱!可现实却泼了盆冷水,吉利德向《Fierce Biotech》透露,“最近终止了这两项试验,原因是北半球最近的 RSV 流行季,发病率低得超乎想象,根本没法确定药物是否真能有效缓解症状,而这恰恰是研究的核心目标。”但尴尬的是,吉利德研发管线里,再没其他 RSV 候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627180113a4c0f1fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627180113a4c0f1fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","IE00BKVL7J92.USD","BK4139","LU1839511570.USD","BK4588","BK4550","LU1585245621.USD","LU2468319806.SGD","LU1674673691.USD","SG9999015945.SGD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","GILD","LU0289739699.SGD","BK4585","IE00BSNM7G36.USD","BK4568","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU0320765992.SGD","SG9999015978.USD","LU1066053197.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU0234570918.USD","LU2089984988.USD","LU0109394709.USD","BK4578","SG9999015952.SGD","LU1674673428.USD","LU1430594728.SGD","LU0889565916.HKD","LU0058720904.USD","IE00B19Z3B42.SGD","BK4583","BK4566","LU0823416689.USD","SG9999015986.USD","LU1778281490.HKD","LU1066051498.USD"],"gpt_icon":0},{"id":"2546760949","title":"诺华制药6月26日成交额为1.97亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546760949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546760949?lang=zh_cn&edition=fundamental","pubTime":"2025-06-27 12:14","pubTimestamp":1750997673,"startTime":"0","endTime":"0","summary":"美东时间2025年6月26日,诺华制药成交额为1.97亿美元,成交额较昨日增加78.32%,当日成交量为163.85万股。诺华制药于2025年6月26日涨1.97%,报120.32美元,该股过去5个交易日涨3.76%,年初至今涨28.94%,过去60日涨7.93%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-26|1.97亿|78.32%|163.85万|#|2025-06-25|1.10亿|-10.66%|93.47万|#|2025-06-24|1.23亿|-8.26%|104.07万|#|2025-06-23|1.35亿|-53.07%|114.95万|#|2025-06-20|2.87亿|145.84%|247.32万|诺华开发和生产创新药物。该公司的产品销往全球,其中美国占总收入的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627121442a4c04630&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627121442a4c04630&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE00B4R5TH58.HKD","LU0320765489.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4578","LU0208291251.USD","BK4532","BK4588","IE00BJT1NW94.SGD","IE0002141913.USD","IE0009355771.USD","LU0211331839.USD","NVS","LU0070302665.USD","IE00BJJMRZ35.SGD","BK4585"],"gpt_icon":0},{"id":"2546227671","title":"吉利德科学6月25日成交额为6.40亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546227671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546227671?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 10:16","pubTimestamp":1750904189,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日,吉利德科学成交额为6.40亿美元,成交额较昨日减少24.57%,当日成交量为605.36万股。吉利德科学于2025年6月25日跌1.18%,报105.93美元,该股过去5个交易日跌1.92%,年初至今涨16.31%,过去60日跌4.56%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权,该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626101631a71e01d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626101631a71e01d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1839511570.USD","BK4566","LU1585245621.USD","LU0234570918.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","LU0823416689.USD","IE00B19Z3581.USD","BK4550","GILD","SG9999015978.USD","BK4583","BK4588","BK4532","LU0289739699.SGD","SG9999015952.SGD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU2087621335.USD","LU0320765992.SGD","SG9999015986.USD","BK4568","BK4578","BK4139","IE00B3T34201.USD","LU0058720904.USD","IE00B7SZLL34.SGD","LU1066051498.USD","BK4585","LU1778281490.HKD","LU2089984988.USD","LU1674673691.USD","LU0109394709.USD","LU1066053197.SGD","LU1571399168.USD","LU1430594728.SGD","IE00BZ1G4Q59.USD","IE0002270589.USD","LU1674673428.USD","LU2468319806.SGD","SG9999015945.SGD"],"gpt_icon":0},{"id":"2546264592","title":"BUZZ-Kymera Therapeutics 发行 2.5 亿美元股票后下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2546264592","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546264592?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 05:03","pubTimestamp":1750885423,"startTime":"0","endTime":"0","summary":"** Kymera TherapeuticsKYMR.O盘后股价下跌5.2%,报44.04美元,该公司正寻求融资。** 总部位于马萨诸塞州沃特敦的公司开始发行 2.5 亿美元的股票。** 另外,Kymera称赛诺菲SASY.PA将推进 ,其KT-485候选药物将进入临床试验阶段,Kymera有资格获得高达9.75亿美元的合作里程碑付款。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nL4S3SS1HT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","BK4516","LU0823416689.USD","LU0889565916.HKD","LU1430594728.SGD","LU2089284900.SGD","IE00B7SZLL34.SGD","LU0225283273.USD","LU1363072403.SGD","LU0971096721.USD","BK4578","LU0058720904.USD","LU1074936037.SGD","LU1989772840.SGD","BK4534","LU1778281490.HKD","SG9999015986.USD","BK4127","LU1989772923.USD","LU1839511570.USD","IE00BKVL7J92.USD","GILD","LU2028103732.USD","IE00B19Z3B42.SGD","LU0320765646.SGD","LU0912757837.SGD","BK4550","LU1674673691.USD","LU2347655156.SGD","LU1585245621.USD","LU2468319806.SGD","KYMR","LU2271345857.HKD","LU0795875169.SGD","LU1732799900.SGD","LU1720051108.HKD","BK4568","IE00B19Z3581.USD","LU2023251221.USD","LU1674673428.USD","LU0006306889.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","BK4585","LU2089984988.USD","BK4581","LU0158827948.USD","LU1571399168.USD","BK4139","LU2111349929.HKD"],"gpt_icon":0},{"id":"2546424890","title":"吉利德与 Kymera Therapeutics 签订价值 7.5 亿美元的抗癌药物协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2546424890","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546424890?lang=zh_cn&edition=fundamental","pubTime":"2025-06-25 21:02","pubTimestamp":1750856542,"startTime":"0","endTime":"0","summary":"吉利德与 Kymera Therapeutics 签订价值 7.5 亿美元的抗癌药物协议路透6月25日 - 吉利德科学公司GILD.O与Kymera TherapeuticsKYMR.O周三表示,双方已达成一项选择权和许可协议,以支持一类抗癌药物的开发和销售。根据协议,Kymera 还有资格从这些药物的净销售额中获得分级版税。与抑制相关蛋白作用的传统抗癌药物相比,Kymera 的药物旨在选择性地消除名为 CDK2 或细胞周期蛋白依赖性激酶 2 的蛋白。两家公司表示,与 Kymera 的交易预计将使吉利德公司 2025 年的每股利润减少约 2 到 3 美分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nL4T3SS0Z8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","BK4583","SG9999015952.SGD","IE0002270589.USD","LU1839511570.USD","LU0889565916.HKD","LU1674673691.USD","BK4550","IE00BSNM7G36.USD","SG9999015978.USD","BK4568","LU0289739699.SGD","LU0320765992.SGD","LU2468319806.SGD","GILD","BK4532","LU1066053197.SGD","IE00B3T34201.USD","KYMR","IE00B19Z3581.USD","IE00BKVL7J92.USD","SG9999015986.USD","LU1674673428.USD","LU1430594728.SGD","IE00B7SZLL34.SGD","LU0109394709.USD","LU0234570918.USD","BK4566","LU2089984988.USD","LU1066051498.USD","LU1571399168.USD","BK4588","LU0823416689.USD","BK4585","BK4578","LU2087621335.USD","SG9999015945.SGD","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU0058720904.USD","IE00B19Z3B42.SGD","BK4139"],"gpt_icon":0},{"id":"2546534264","title":"诺华制药6月24日成交额为1.23亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546534264","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546534264?lang=zh_cn&edition=fundamental","pubTime":"2025-06-25 12:24","pubTimestamp":1750825489,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日,诺华制药成交额为1.23亿美元,成交额较昨日减少8.26%,当日成交量为104.07万股。诺华制药于2025年6月24日涨1.11%,报118.83美元,该股过去5个交易日涨0.63%,年初至今涨27.34%,过去60日涨6.67%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-24|1.23亿|-8.26%|104.07万|#|2025-06-23|1.35亿|-53.07%|114.95万|#|2025-06-20|2.87亿|145.84%|247.32万|#|2025-06-18|1.17亿|-23.71%|100.50万|#|2025-06-17|1.53亿|-0.98%|130.64万|诺华开发和生产创新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625122455a4bc9b12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625122455a4bc9b12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","LU0211331839.USD","LU0320765489.SGD","NVS","BK4578","IE0002141913.USD","LU0208291251.USD","LU0070302665.USD","IE00BJT1NW94.SGD","BK4007","IE00B2B36J28.USD","BK4588","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4585","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2546630042","title":"吉利德科学6月24日成交额为8.48亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546630042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546630042?lang=zh_cn&edition=fundamental","pubTime":"2025-06-25 10:13","pubTimestamp":1750817634,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日,吉利德科学成交额为8.48亿美元,成交额较昨日减少2.42%,当日成交量为791.70万股。吉利德科学于2025年6月24日涨0.95%,报107.2美元,该股过去5个交易日跌3.28%,年初至今涨17.71%,过去60日跌2.87%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权,该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625101404a71c27ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625101404a71c27ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","LU2089984988.USD","LU0823416689.USD","SG9999015945.SGD","LU1674673428.USD","LU1778281490.HKD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","IE0002270589.USD","SG9999015986.USD","LU1674673691.USD","BK4566","BK4578","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","BK4568","LU0320765992.SGD","SG9999015952.SGD","LU1066051498.USD","BK4585","BK4550","IE00B3T34201.USD","BK4139","LU0058720904.USD","LU0234570918.USD","LU1839511570.USD","GILD","LU2468319806.SGD","LU2087621335.USD","LU1066053197.SGD","BK4588","LU0889565916.HKD","IE00B19Z3581.USD","LU0289739699.SGD","BK4583","LU0109394709.USD","LU1571399168.USD","LU1585245621.USD","IE00B19Z3B42.SGD","LU1430594728.SGD","SG9999015978.USD"],"gpt_icon":0},{"id":"2545795534","title":"诺华制药6月23日成交额为1.35亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545795534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545795534?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 12:23","pubTimestamp":1750739017,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日,诺华制药成交额为1.35亿美元,成交额较昨日减少53.07%,当日成交量为114.95万股。诺华制药于2025年6月23日涨1.51%,报117.52美元,该股过去5个交易日跌1.62%,年初至今涨25.94%,过去60日涨6.7%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-23|1.35亿|-53.07%|114.95万|#|2025-06-20|2.87亿|145.84%|247.32万|#|2025-06-18|1.17亿|-23.71%|100.50万|#|2025-06-17|1.53亿|-0.98%|130.64万|#|2025-06-16|1.54亿|1.21%|130.13万|诺华开发和生产创新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624122347a4bac2e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624122347a4bac2e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002141913.USD","LU0208291251.USD","LU0070302665.USD","LU0211331839.USD","NVS","BK4007","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","BK4588","BK4532","IE0009355771.USD","BK4578","BK4585","LU0320765489.SGD"],"gpt_icon":0},{"id":"2545478854","title":"吉利德科学6月23日成交额为8.69亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545478854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545478854?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 10:13","pubTimestamp":1750731220,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日,吉利德科学成交额为8.69亿美元,成交额较昨日减少65.61%,当日成交量为817.34万股。吉利德科学于2025年6月23日跌2.13%,报106.19美元,该股过去5个交易日跌3.45%,年初至今涨16.6%,过去60日跌2.12%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权,该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624101342a4ba9143&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624101342a4ba9143&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2468319806.SGD","IE0002270589.USD","GILD","BK4568","IE00BKVL7J92.USD","BK4532","LU0320765992.SGD","BK4550","LU1585245621.USD","IE00B7SZLL34.SGD","LU1674673691.USD","IE00B19Z3581.USD","LU2087621335.USD","BK4585","LU1839511570.USD","LU0289739699.SGD","LU0058720904.USD","LU0889565916.HKD","BK4578","LU1571399168.USD","BK4139","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU1066051498.USD","LU1674673428.USD","LU1778281490.HKD","BK4588","LU0823416689.USD","LU0234570918.USD","LU0109394709.USD","LU1066053197.SGD","IE00BSNM7G36.USD","BK4566","IE00B3T34201.USD","BK4583","LU2089984988.USD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2545102796","title":"诺华制药6月20日成交额为2.87亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545102796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545102796?lang=zh_cn&edition=fundamental","pubTime":"2025-06-21 12:21","pubTimestamp":1750479662,"startTime":"0","endTime":"0","summary":"美东时间2025年6月20日,诺华制药成交额为2.87亿美元,成交额较昨日增加145.84%,当日成交量为247.32万股。诺华制药于2025年6月20日跌0.16%,报115.77美元,该股过去5个交易日跌4.14%,年初至今涨24.06%,过去60日涨4.88%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-20|2.87亿|145.84%|247.32万|#|2025-06-18|1.17亿|-23.71%|100.50万|#|2025-06-17|1.53亿|-0.98%|130.64万|#|2025-06-16|1.54亿|1.21%|130.13万|#|2025-06-13|1.53亿|5.10%|127.67万|诺华开发和生产创新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621122113a7159a20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621122113a7159a20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","BK4588","IE00BJT1NW94.SGD","LU0320765489.SGD","LU0208291251.USD","IE00BFTCPJ56.SGD","BK4585","LU0211331839.USD","LU0070302665.USD","BK4578","IE00BJJMRZ35.SGD","NVS","IE00B4R5TH58.HKD","BK4532"],"gpt_icon":0},{"id":"2545101440","title":"吉利德科学6月20日成交额为25.27亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545101440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545101440?lang=zh_cn&edition=fundamental","pubTime":"2025-06-21 10:13","pubTimestamp":1750472028,"startTime":"0","endTime":"0","summary":"美东时间2025年6月20日,吉利德科学成交额为25.27亿美元,成交额较昨日增加80.36%,当日成交量为2326.81万股。吉利德科学于2025年6月20日涨0.46%,报108.5美元,该股过去5个交易日跌2.48%,年初至今涨19.14%,过去60日涨1.28%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权,该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621101353a4b59697&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621101353a4b59697&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2087621335.USD","LU2468319806.SGD","LU0823416689.USD","LU1585245621.USD","BK4588","LU1839511570.USD","IE00B19Z3581.USD","LU0234570918.USD","IE00B19Z3B42.SGD","LU1066051498.USD","GILD","IE00BSNM7G36.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","BK4578","BK4585","IE0002270589.USD","IE00B7SZLL34.SGD","LU1778281490.HKD","LU0889565916.HKD","BK4532","BK4550","BK4566","IE00BKVL7J92.USD","LU0058720904.USD","LU1674673428.USD","LU0320765992.SGD","BK4583","LU1674673691.USD","BK4139","LU1571399168.USD","IE00B3T34201.USD","LU0109394709.USD","BK4568","LU1066053197.SGD","LU0289739699.SGD","LU1430594728.SGD"],"gpt_icon":0},{"id":"2544418146","title":"美股异动丨吉利德科学盘前涨超2% 艾滋病预防明星药获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2544418146","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544418146?lang=zh_cn&edition=fundamental","pubTime":"2025-06-20 16:12","pubTimestamp":1750407175,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B7SZLL34.SGD","BK4568","LU0889565916.HKD","LU2089984988.USD","IE00B19Z3B42.SGD","LU1571399168.USD","IE00BZ1G4Q59.USD","IE00B3T34201.USD","BK4588","LU1585245621.USD","LU0058720904.USD","LU1674673691.USD","LU2468319806.SGD","LU1430594728.SGD","IE00BSNM7G36.USD","BK4585","GILD","LU0109394709.USD","LU0320765992.SGD","LU0823416689.USD","LU0234570918.USD","LU1839511570.USD","LU2087621335.USD","LU1066053197.SGD","LU1674673428.USD","LU0289739699.SGD","LU1066051498.USD","LU1778281490.HKD","BK4139","BK4578","BK4550","BK4566","IE00BKVL7J92.USD","IE00B19Z3581.USD","BK4532","IE0002270589.USD","BK4583"],"gpt_icon":0},{"id":"2544990119","title":"【高盛:予吉利德(GILD.US)“中性”评级 长效HIV疗法迎来重大机遇】智通财经APP获悉,高盛发布研报,予吉利德科","url":"https://stock-news.laohu8.com/highlight/detail?id=2544990119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544990119?lang=zh_cn&edition=fundamental","pubTime":"2025-06-20 11:12","pubTimestamp":1750389160,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1571399168.USD","IE0004091025.USD","LU0823416689.USD","LU2237443549.SGD","LU0742534661.SGD","LU1585245621.USD","LU2468319806.SGD","LU1868837300.USD","LU2471134796.USD","LU2237443978.SGD","BK4585","LU0320765992.SGD","LU1868836591.USD","LU0251142724.SGD","BK4566","LU1066053197.SGD","LU1868836914.USD","LU1674673691.USD","GILD","LU1430594728.SGD","LU2237443465.HKD","LU2750360641.GBP","LU1868836757.USD","LU1066051498.USD","LU0889565916.HKD","LU1791807156.HKD","LU2471134879.HKD","IE00B3T34201.USD","IE00B19Z3581.USD","LU0061475181.USD","BK4583","LU0058720904.USD","IE00B19Z3B42.SGD","LU0234570918.USD","LU1894683264.USD","BK4578","BK4127","BK4533","BK4532","LU1868837136.USD","LU2237438978.USD","BK4588","IE00BKVL7J92.USD","IE00BFXG1179.USD","LU2471134952.CNY","BK4139","IE00BSNM7G36.USD","BK4504","BK4568","LU0048573561.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}]}}